Fig. 2.
Study flow sheet. The European Pharmacogenetic Opioid Study included 2,294 cancer patients of whom 461 were treated with oxycodone. Four hundred and forty-four used oral oxycodone, 439 were included in the analyses
Study flow sheet. The European Pharmacogenetic Opioid Study included 2,294 cancer patients of whom 461 were treated with oxycodone. Four hundred and forty-four used oral oxycodone, 439 were included in the analyses